Talus Bio
ActiveDiscovering drugs that target the DNA regulome
What it does
We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.
Its site says now · captured 2026-08-23
Talus Bio | Unlocking the Regulome for Drug Discovery
Talus Bio makes the regulome—the control layer of gene expression—visible, measuring and modulating gene regulators in live cells to access new drug targets and enable first-in-class medicines.
Next to it in Healthcare and bio · DNA regulome drug discovery
- Valink TherapeuticsY Combinator W21
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
- AlixiaY Combinator W22
Targeting the Tumor Ecosystem to address cancer drug resistance.
- Rosebud BiosciencesY Combinator W22
Growing micro-organs to find new drugs
- Known MedicineY Combinator S20
Combining 3D cell culture & AI to translate drugs to clinical success
- Arpeggio BioY Combinator S19
Arpeggio Bio develops drugs targeting transcription factors using AI…
- Intrinsic Medicine (fka Lupa Bio)SOSV SOSV IndieBio 09
Developing the next generation of essential, disease-modifying medicines
- Civetbio500 Global
Provider of biotechnology service intended to accelerate drug discovery for live bio-therapeutics. The company's service includes a microbiota bank, a clinical intervention platform, and core big data technology that powers their bioinformatics pipeline, enabling researchers to characterize the Asian gut microbiome and understand the varying profiles across country regions.
- Exin TherapeuticsY Combinator W25
AI drug discovery platform for neurotherapeutics